Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06613009
Title Study of IBI3009 in Subjects With Unresectable, Locally Advanced or Metastatic Small Cell Lung Cancer and Other Neuroendocrine Carcinomas
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Innovent Biologics (Suzhou) Co. Ltd.
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS


No variant requirements are available.